These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24118636)

  • 1. Protection against hepatitis E virus infection by naturally acquired and vaccine-induced immunity.
    Zhang J; Zhang XF; Zhou C; Wang ZZ; Huang SJ; Yao X; Liang ZL; Wu T; Li JX; Yan Q; Yang CL; Jiang HM; Huang HJ; Xian YL; Shih JW; Ng MH; Li YM; Wang JZ; Zhu FC; Xia NS
    Clin Microbiol Infect; 2014 Jun; 20(6):O397-405. PubMed ID: 24118636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial.
    Zhu FC; Zhang J; Zhang XF; Zhou C; Wang ZZ; Huang SJ; Wang H; Yang CL; Jiang HM; Cai JP; Wang YJ; Ai X; Hu YM; Tang Q; Yao X; Yan Q; Xian YL; Wu T; Li YM; Miao J; Ng MH; Shih JW; Xia NS
    Lancet; 2010 Sep; 376(9744):895-902. PubMed ID: 20728932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of antibodies acquired by natural hepatitis E virus infection and effects of vaccination.
    Su YY; Huang SJ; Guo M; Zhao J; Yu H; He WG; Jiang HM; Wang YJ; Zhang XF; Cai JP; Yang CL; Wang ZZ; Zhu FC; Wu T; Zhang J; Xia NS
    Clin Microbiol Infect; 2017 May; 23(5):336.e1-336.e4. PubMed ID: 27836809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of a recombinant hepatitis E vaccine.
    Shrestha MP; Scott RM; Joshi DM; Mammen MP; Thapa GB; Thapa N; Myint KS; Fourneau M; Kuschner RA; Shrestha SK; David MP; Seriwatana J; Vaughn DW; Safary A; Endy TP; Innis BL
    N Engl J Med; 2007 Mar; 356(9):895-903. PubMed ID: 17329696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term efficacy of a hepatitis E vaccine.
    Zhang J; Zhang XF; Huang SJ; Wu T; Hu YM; Wang ZZ; Wang H; Jiang HM; Wang YJ; Yan Q; Guo M; Liu XH; Li JX; Yang CL; Tang Q; Jiang RJ; Pan HR; Li YM; Shih JW; Ng MH; Zhu FC; Xia NS
    N Engl J Med; 2015 Mar; 372(10):914-22. PubMed ID: 25738667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the long-term antibody response of a hepatitis E vaccine.
    Chen S; Zhou Z; Wei FX; Huang SJ; Tan Z; Fang Y; Zhu FC; Wu T; Zhang J; Xia NS
    Vaccine; 2015 Aug; 33(33):4124-9. PubMed ID: 26126668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenicity of hepatitis E vaccine in elderly people older than 65 years.
    Yu XY; Chen ZP; Wang SY; Pan HR; Wang ZF; Zhang QF; Shen LZ; Zheng XP; Yan CF; Lu M; Chen B; Zheng Y; Zhang J; Lv HK; Huang SJ
    Vaccine; 2019 Jul; 37(32):4581-4586. PubMed ID: 31262585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of new hepatitis E vaccines.
    Cao Y; Bing Z; Guan S; Zhang Z; Wang X
    Hum Vaccin Immunother; 2018; 14(9):2254-2262. PubMed ID: 29708836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis E vaccine immunization for rabbits to prevent animal HEV infection and zoonotic transmission.
    Zhang Y; Zeng H; Liu P; Liu L; Xia J; Wang L; Zou Q; Wang L; Zhuang H
    Vaccine; 2015 Sep; 33(38):4922-8. PubMed ID: 26212003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives of vaccination against hepatitis E.
    Safary A
    Intervirology; 2001; 44(2-3):162-6. PubMed ID: 11509877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine.
    Purcell RH; Nguyen H; Shapiro M; Engle RE; Govindarajan S; Blackwelder WC; Wong DC; Prieels JP; Emerson SU
    Vaccine; 2003 Jun; 21(19-20):2607-15. PubMed ID: 12744897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis E virus: Current epidemiology and vaccine.
    Wu X; Chen P; Lin H; Hao X; Liang Z
    Hum Vaccin Immunother; 2016 Oct; 12(10):2603-2610. PubMed ID: 27184971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodal investigation of rat hepatitis E virus antigenicity: Implications for infection, diagnostics, and vaccine efficacy.
    Sridhar S; Situ J; Cai JP; Yip CC; Wu S; Zhang AJ; Wen L; Chew NF; Chan WM; Poon RW; Chan JF; Tsang DN; Chen H; Xia NS; Yuen KY
    J Hepatol; 2021 Jun; 74(6):1315-1324. PubMed ID: 33845058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons from hepatitis E vaccine design.
    Li S; Zhang J; Xia N
    Curr Opin Virol; 2015 Apr; 11():130-6. PubMed ID: 25913817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis E vaccine development: a 14 year odyssey.
    Wu T; Li SW; Zhang J; Ng MH; Xia NS; Zhao Q
    Hum Vaccin Immunother; 2012 Jun; 8(6):823-7. PubMed ID: 22699438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HEV study protocol : design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women of childbearing age in rural Bangladesh.
    Zaman K; Dudman S; Stene-Johansen K; Qadri F; Yunus M; Sandbu S; Gurley ES; Overbo J; Julin CH; Dembinski JL; Nahar Q; Rahman A; Bhuiyan TR; Rahman M; Haque W; Khan J; Aziz A; Khanam M; Streatfield PK; Clemens JD
    BMJ Open; 2020 Jan; 10(1):e033702. PubMed ID: 31959609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and safety of hepatitis E vaccine in healthy hepatitis B surface antigen positive adults.
    Wu T; Huang SJ; Zhu FC; Zhang XF; Ai X; Yan Q; Wang ZZ; Yang CL; Jiang HM; Liu XH; Guo M; Du HL; Ng MH; Zhang J; Xia NS
    Hum Vaccin Immunother; 2013 Nov; 9(11):2474-9. PubMed ID: 23887167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of autophagy induction on HEV 239 vaccine immune response in a mouse model.
    Khateri M; Abdoli A; Motevalli F; Fotouhi F; Bolhassani A; Arashkia A; Jazaeri EO; Shahbazi S; Mehrbod P; Naziri H; Aghasadeghi MR
    IUBMB Life; 2018 Mar; 70(3):207-214. PubMed ID: 29369472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of 8G12 competitive antibody in "prime-boost" vaccination of Hepatitis E vaccine.
    Wu X; Chen P; Lin H; Su Y; Hao X; Cao Y; Li L; Zhu F; Liang Z
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-6. PubMed ID: 28272983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective efficacy of hepatitis E virus DNA vaccine administered by gene gun in the cynomolgus macaque model of infection.
    Kamili S; Spelbring J; Carson D; Krawczynski K
    J Infect Dis; 2004 Jan; 189(2):258-64. PubMed ID: 14722891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.